Item 1A. Risk Factors
2K characters. Original on sec.gov ·
Item 1A. Risk Factors
For a discussion of risk factors affecting the Company's business, refer to the “Risk Factors" section in Part I, Item 2 of this report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities*
The following table presents information related to repurchases of common stock the Company made during the quarter ended September 30, 2026:
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1) | |||||||||||||||||||
| July 1-31, 2026 | 853,497 | $ | 273.79 | 853,497 | $ | 11,498,131,539 | |||||||||||||||||
| August 1-31, 2026 | 619,356 | 271.51 | 619,356 | 11,329,969,897 | |||||||||||||||||||
| September 1-30, 2026 | 465,344 | 251.45 | 465,344 | 11,212,958,001 | |||||||||||||||||||
| Total | 1,938,197 | $ | 267.70 | 1,938,197 |
*Subject to applicable law, the Company may repurchase shares directly in the open market, in privately negotiated transactions or pursuant to derivative instruments and plans complying with Rule 10b5-1 under the Exchange Act, among other types of transactions and arrangements.
(1)As disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, the Company's Board of Directors approved a share repurchase program on November 21, 2024, effective January 1, 2025 with no specified expiration date, that authorized the purchase of up to $15.0 billion of the Company's outstanding common stock.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information